Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
1.280
+0.020 (1.59%)
Mar 26, 2026, 4:00 PM EDT - Market closed

Treace Medical Concepts Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
831564647871,2791,010
Market Cap Growth
-83.79%-66.28%-41.07%-38.44%26.63%-
Enterprise Value
106.17177.66457.53732.991,266933.47
Last Close Price
1.282.457.4412.7522.9918.64
PE Ratio
--2.63-8.27-15.74-29.86-43.35
PS Ratio
0.390.742.224.219.0210.70
PB Ratio
0.941.794.115.7121.1310.85
P/TBV Ratio
0.931.784.095.6321.009.70
P/FCF Ratio
--5.31-9.52-17.10-28.12-50.76
P/OCF Ratio
--9.80-12.48-22.77-41.73-58.74
EV/Sales Ratio
0.500.842.193.928.929.89
EV/EBITDA Ratio
--4.08-9.68-15.91-38.70-58.99
EV/EBIT Ratio
--3.28-8.22-14.25-36.33-56.54
EV/FCF Ratio
--6.03-9.38-15.92-27.83-46.91
Debt / Equity Ratio
0.800.800.610.501.130.32
Debt / EBITDA Ratio
-1.60-1.60-1.46-1.49-2.09-1.86
Debt / FCF Ratio
-2.36-2.36-1.42-1.50-1.50-1.48
Net Debt / Equity Ratio
0.240.24-0.06-0.39-0.21-0.82
Net Debt / EBITDA Ratio
-0.49-0.490.141.180.404.83
Net Debt / FCF Ratio
-0.72-0.720.131.180.293.84
Asset Turnover
1.041.040.890.910.951.03
Inventory Turnover
1.141.141.201.451.711.84
Quick Ratio
2.952.953.343.583.656.83
Current Ratio
4.314.314.624.404.417.58
Return on Equity (ROE)
-58.94%-58.94%-44.45%-49.91%-55.75%-43.80%
Return on Assets (ROA)
-26.57%-26.57%-23.75%-25.03%-23.24%-18.08%
Return on Invested Capital (ROIC)
-49.01%-49.01%-57.08%-75.64%-107.80%-107.57%
Return on Capital Employed (ROCE)
-31.66%-31.66%-28.63%-30.64%-27.72%-21.61%
Earnings Yield
-71.37%-37.96%-12.10%-6.35%-3.35%-2.31%
FCF Yield
-35.67%-18.85%-10.51%-5.85%-3.56%-1.97%
Buyback Yield / Dilution
-1.86%-1.86%-2.07%-10.09%-14.17%-30.61%
Total Shareholder Return
-1.86%-1.86%-2.07%-10.09%-14.17%-30.61%
Updated Feb 27, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q